Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / *W EXP 09/24/202
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
2,014,163
-
Shares change
-
-500,578
-
Total reported value, excl. options
-
$2,970,000
-
Value change
-
-$731,361
-
Number of buys
-
4
-
Number of sells
-
13
-
Price
-
$1.47
Institutional Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) as of Q4 2021
As of 31 Dec 2021 Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) had 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,014,163 shares of stock of the company.
Largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, Owl Creek Asset Management, L.P., Ionic Capital Management LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Shaolin Capital Management LLC, Privium Fund Management B.V., RIVERNORTH CAPITAL MANAGEMENT, LLC, Integrity Capital Management (HK) Ltd, EQUITEC PROPRIETARY MARKETS, LLC, and HRT FINANCIAL LP.
This table shows 22 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.